Inflammation and premature aging in advanced chronic kidney disease
JP Kooman, MJ Dekker, LA Usvyat… - American Journal …, 2017 - journals.physiology.org
Systemic inflammation in end-stage renal disease is an established risk factor for mortality
and a catalyst for other complications, which are related to a premature aging phenotype …
and a catalyst for other complications, which are related to a premature aging phenotype …
Chronic kidney disease: effects on the cardiovascular system
EL Schiffrin, ML Lipman, JFE Mann - Circulation, 2007 - Am Heart Assoc
Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic
kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the …
kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the …
[HTML][HTML] IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good,
the bad, and the ugly. It has been increasingly apparent that wasting and cardiovascular …
the bad, and the ugly. It has been increasingly apparent that wasting and cardiovascular …
Arterial stiffness: a focus on vascular calcification and its link to bone mineralization
This review focuses on the association between vascular calcification and arterial stiffness,
highlighting the important genetic factors, systemic and local microenvironmental signals …
highlighting the important genetic factors, systemic and local microenvironmental signals …
Fetuin-A regulation of calcified matrix metabolism
W Jahnen-Dechent, A Heiss, C Schäfer… - Circulation …, 2011 - Am Heart Assoc
The final step of biomineralization is a chemical precipitation reaction that occurs
spontaneously in supersaturated or metastable salt solutions. Genetic programs direct …
spontaneously in supersaturated or metastable salt solutions. Genetic programs direct …
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
P Stenvinkel, J Jesu, J Axelsson… - Clinical journal of the …, 2008 - journals.lww.com
Premature cardiovascular disease (CVD), including stroke, peripheral vascular disease,
sudden death, coronary artery disease, and congestive heart failure, is a notorious problem …
sudden death, coronary artery disease, and congestive heart failure, is a notorious problem …
Inflammation in end‐stage renal disease—what have we learned in 10 years?
JJ Carrero, P Stenvinkel - Seminars in dialysis, 2010 - Wiley Online Library
The first reports connecting uremic inflammation with a wasted and atherogenic phenotype
and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on …
and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on …
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
H Honda, AR Qureshi, O Heimbürger, P Barany… - American Journal of …, 2006 - Elsevier
Background: Serum albumin (S-Alb), C-reactive protein (CRP), and interleukin 6 (IL-6)
predict malnutrition, atherosclerotic cardiovascular disease (CVD), and mortality in patients …
predict malnutrition, atherosclerotic cardiovascular disease (CVD), and mortality in patients …
Fetuin-A and incident diabetes mellitus in older persons
Context Fetuin-A is a hepatic secretory protein that binds the insulin receptor and inhibits
insulin action in vitro. In prior cross-sectional studies in humans, higher fetuin-A levels were …
insulin action in vitro. In prior cross-sectional studies in humans, higher fetuin-A levels were …
Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification
JL Reynolds, JN Skepper, R McNair… - Journal of the …, 2005 - journals.lww.com
Vascular calcification predicts an increased risk for cardiovascular events/mortality in
atherosclerosis, diabetes, and ESRD. Serum concentrations of α 2-Heremens-Schmid …
atherosclerosis, diabetes, and ESRD. Serum concentrations of α 2-Heremens-Schmid …